FIELD: medicine; neurology; immunology.
SUBSTANCE: invention relates to the field of medicine, namely to neurology and immunology; it is intended for the treatment of multiple sclerosis. A method for the treatment of multiple sclerosis in a patient who needs it includes oral administration to the specified patient of a daily dose of 0.5 mg of a drug selected from fingolimod (hereinafter – FTY720), its phosphate derivative or its pharmaceutically acceptable salt. In addition, the method includes identification of the medical history of eyes of the patient subjected to the treatment before the treatment with fingolimod (FTY720), its phosphate derivative or its pharmaceutically acceptable salt, as well as conduction of ophthalmological examinations performed 3-4 months after the treatment with FTY720, its phosphate derivative or its pharmaceutically acceptable salt, preferably by an ophthalmologist, wherein the specified examinations include checking and/or monitoring the appearance of macular edema.
EFFECT: use of the invention allows for increasing the efficiency and safety of the treatment of multiple sclerosis in a patient.
2 cl, 2 ex
